Company Filing History:
Years Active: 2007
Title: Kerry Anne Rye: Innovator in Sphingosine Kinase Detection
Introduction
Kerry Anne Rye is a notable inventor based in South Australia, Australia. She has made significant contributions to the field of biochemistry, particularly in the detection of sphingosine kinase activity. Her work has implications for understanding various biological processes and potential therapeutic applications.
Latest Patents
Kerry Anne Rye holds 1 patent for her invention titled "Detection of sphingosine kinase activity and sphingosine kinase agonist or antagonist activity." This invention relates to methods for detecting sphingosine kinase activity, which is crucial for various cellular functions and signaling pathways.
Career Highlights
Kerry Anne Rye is currently employed at Johnson & Johnson Pharmaceutical Research & Development, LLC. Her role at this prestigious company allows her to engage in cutting-edge research and development in the pharmaceutical sector.
Collaborations
Throughout her career, Kerry has collaborated with esteemed colleagues, including Jennifer Ruth Gamble and Mathew A Vadas. These collaborations have further enriched her research and contributed to advancements in her field.
Conclusion
Kerry Anne Rye's innovative work in sphingosine kinase detection exemplifies her commitment to advancing scientific knowledge and therapeutic development. Her contributions are valuable to both the scientific community and the pharmaceutical industry.